TOP 008

Drug Profile

TOP 008

Alternative Names: TOP-008

Latest Information Update: 11 Dec 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nippon Chemiphar
  • Developer Hitachi Chemical; Nippon Chemiphar; Nonindustrial source
  • Class Antineoplastics; Piperazines
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 11 Dec 2007 Discontinued - Preclinical for Cancer in USA (unspecified route)
  • 06 Mar 2001 Preclinical development for Cancer in Japan (Unknown route)
  • 06 Mar 2001 Preclinical development for Cancer in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top